[Von Recklinghausen's disease: experimental models and comparative aspects]

Area of Science:

• Genetics
• Oncology
• Toxicology

Background:

• Neurofibromatosis type 1 (NF-1) is an autosomal dominant syndrome with diverse tumorous and non-tumorous manifestations.
• NF-1 gene is located on chromosome 17, distinct from NF-2 on chromosome 22.
• Both hereditary and sporadic forms of NF-1 are recognized.

Purpose of the Study:

• To investigate the potential of environmental mutagens, ethylnitrosourea (ENU) and methylnitrosourea (MNU), in modeling sporadic NF-1.
• To explore the possibility of transgenerational transmission of ENU's carcinogenic effects to model hereditary NF-1.
• To compare tumor characteristics induced by direct ENU exposure versus transgenerational effects.

Main Methods:

• Transplacental administration of ENU and MNU to pregnant rats to induce tumors.
• Observation of tumor spectrum and location in offspring following prenatal mutagen exposure.
• Analysis of neu oncogene mutations in tumors from directly treated and untreated offspring of ENU-exposed rats.

Main Results:

• Tumor spectrum induced by ENU/MNU in rats partially mimicked human sporadic NF-1.
• Prenatal ENU exposure in rats led to an increased incidence of tumors in untreated offspring, suggesting transgenerational effects.
• Tumors in untreated descendants showed significantly lower rates of specific neu oncogene mutations compared to tumors from directly treated rats.

Conclusions:

• Environmental mutagens like ENU can effectively model sporadic NF-1 tumor development.
• Transgenerational effects of ENU provide a potential model for studying hereditary NF-1.
• Mechanisms of transgenerational carcinogenesis warrant further investigation, with implications for understanding inherited cancer predispositions.